These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 14978245)

  • 21. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain.
    Nicholson RA; Liao C; Zheng J; David LS; Coyne L; Errington AC; Singh G; Lees G
    Brain Res; 2003 Jul; 978(1-2):194-204. PubMed ID: 12834914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones.
    Straiker A; Mackie K
    J Physiol; 2005 Dec; 569(Pt 2):501-17. PubMed ID: 16179366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
    Huang CC; Lo SW; Hsu KS
    J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.
    Lauckner JE; Hille B; Mackie K
    Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19144-9. PubMed ID: 16365309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.
    Mackie K; Devane WA; Hille B
    Mol Pharmacol; 1993 Sep; 44(3):498-503. PubMed ID: 8371711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices.
    Ameri A; Simmet T
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):265-72. PubMed ID: 10731038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms underlying cannabinoid inhibition of presynaptic Ca2+ influx at parallel fibre synapses of the rat cerebellum.
    Daniel H; Rancillac A; Crepel F
    J Physiol; 2004 May; 557(Pt 1):159-74. PubMed ID: 15034129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide Y receptors differentially modulate G-protein-activated inwardly rectifying K+ channels and high-voltage-activated Ca2+ channels in rat thalamic neurons.
    Sun QQ; Huguenard JR; Prince DA
    J Physiol; 2001 Feb; 531(Pt 1):67-79. PubMed ID: 11179392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid receptor agonists potentiate action potential-independent release of GABA in the dentate gyrus through a CB1 receptor-independent mechanism.
    Hofmann ME; Bhatia C; Frazier CJ
    J Physiol; 2011 Aug; 589(Pt 15):3801-21. PubMed ID: 21646412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse.
    Kushmerick C; Price GD; Taschenberger H; Puente N; Renden R; Wadiche JI; Duvoisin RM; Grandes P; von Gersdorff H
    J Neurosci; 2004 Jun; 24(26):5955-65. PubMed ID: 15229243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation and inhibition of neuronal G protein-gated inwardly rectifying K(+) channels by P2Y nucleotide receptors.
    Filippov AK; Fernández-Fernández JM; Marsh SJ; Simon J; Barnard EA; Brown DA
    Mol Pharmacol; 2004 Sep; 66(3):468-77. PubMed ID: 15322238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands.
    Bajo M; Roberto M; Schweitzer P
    J Neurosci Res; 2009 Feb; 87(3):766-75. PubMed ID: 18816788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-type channel inhibition by CB1 cannabinoid receptors is mediated by PTX-sensitive G proteins and cAMP/PKA in GT1-7 hypothalamic neurons.
    Hoddah H; Marcantoni A; Comunanza V; Carabelli V; Carbone E
    Cell Calcium; 2009; 46(5-6):303-12. PubMed ID: 19818494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.
    Liu Q; Bhat M; Bowen WD; Cheng J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1062-70. PubMed ID: 19752241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
    Terranova JP; Michaud JC; Le Fur G; Soubrié P
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):576-9. PubMed ID: 8751088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors.
    Kelley BG; Thayer SA
    Eur J Pharmacol; 2004 Aug; 496(1-3):33-9. PubMed ID: 15288572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reciprocal inhibition of voltage-gated potassium currents (I K(V)) by activation of cannabinoid CB1 and dopamine D1 receptors in ON bipolar cells of goldfish retina.
    Fan SF; Yazulla S
    Vis Neurosci; 2005; 22(1):55-63. PubMed ID: 15842741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus.
    Di S; Boudaba C; Popescu IR; Weng FJ; Harris C; Marcheselli VL; Bazan NG; Tasker JG
    J Physiol; 2005 Dec; 569(Pt 3):751-60. PubMed ID: 16239276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
    Ameri A; Wilhelm A; Simmet T
    Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depolarization-induced release of endocannabinoids by murine dorsal motor nucleus of the vagus nerve neurons differentially regulates inhibitory and excitatory neurotransmission.
    Roux J; Wanaverbecq N; Jean A; Lebrun B; Trouslard J
    Neuropharmacology; 2009 Jun; 56(8):1106-15. PubMed ID: 19332082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.